A Patient with EGFR Exon 20 Insertion-Mutant Non-Small Cell Lung Cancer Responded to Osimertinib plus Cetuximab Combination Therapy

被引：6
|
作者：
Fang, Wenfeng [1 ]
Huang, Yihua [1 ]
Gan, Jiadi [1 ]
Hong, Shaodong [1 ]
Zhang, Li [1 ]
机构：
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Med Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 09期
基金：
国家重点研发计划;
关键词：
D O I：
10.1016/j.jtho.2019.04.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E201 / E202
页数：2
相关论文
共 50 条
  • [1] Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations
    Hasegawa, Hanako
    Yasuda, Hiroyuki
    Hamamoto, Junk
    Masuzawa, Keita
    Tani, Tetsuo
    Nukaga, Shigenari
    Hirano, Toshiyuki
    Kobayashi, Keigo
    Manabe, Tadashi
    Terai, Hideki
    Ikemura, Shinnosuke
    Kawada, Ichiro
    Naoki, Katsuhiko
    Soejima, Kenzo
    [J]. LUNG CANCER, 2019, 127 : 146 - 152
  • [2] Mechanisms of resistance to mobocertinib in EGFR exon 20 insertion-mutant non-small cell lung cancer (NSCLC)
    Park, S.
    Kim, T. M.
    Kim, S.
    Kim, M.
    Keam, B.
    Kim, D. W.
    Heo, D. S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 174 : S110 - S111
  • [3] A case of non-small cell lung cancer with EGFR exon 20 insertion treated with osimertinib
    Morton-Gittens, Jamie
    Pipalia, Nisarg
    Liu, Hongxiang
    Thippu Jayaprakash, Kamalram
    [J]. LUNG CANCER, 2021, 156 : S73 - S74
  • [4] Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer
    van Veggel, B.
    van der Wekken, A.
    Hashemi, S.
    Cornelissen, R.
    Monkhorst, K.
    Heideman, D.
    Radonic, T.
    Smit, E. F.
    Schuuring, E.
    De Langen, J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [5] Amivantamab for the treatment of EGFR exon 20 insertion mutant non-small cell lung cancer
    Vyse, Simon
    Huang, Paul H.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (01) : 3 - 16
  • [6] EGFR exon 20 insertion mutations in non-small cell lung cancer
    Wang, Fenfang
    Li, Chenghui
    Wu, Qihuan
    Lu, Hongyang
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991
  • [7] EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
    Wenfeng Fang
    Yihua Huang
    Shaodong Hong
    Zhonghan Zhang
    Minghui Wang
    Jiadi Gan
    Wenjing Wang
    Honglin Guo
    Kai Wang
    Li Zhang
    [J]. BMC Cancer, 19
  • [8] EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
    Fang, Wenfeng
    Huang, Yihua
    Hong, Shaodong
    Zhang, Zhonghan
    Wang, Minghui
    Gan, Jiadi
    Wang, Wenjing
    Guo, Honglin
    Wang, Kai
    Zhang, Li
    [J]. BMC CANCER, 2019, 19 (1)
  • [9] Amivantamab in Post-platinum EGFR Exon 20 Insertion Mutant Non-small Cell Lung Cancer
    Sabari, J. K.
    Shu, C. A.
    Park, K.
    Leighl, N.
    Mitchell, P.
    Kim, S.
    Lee, J.
    Kim, D.
    Viteri, S.
    Spira, A.
    Han, J.
    Trigo, J.
    Lee, C. K.
    Lee, K. H.
    Girard, N.
    Yang, T.
    Goto, K.
    Sanborn, R. E.
    Yang, J. C.
    Xie, J.
    Roshak, A.
    Thayu, M.
    Knoblauch, R. E.
    Cho, B. C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S108 - S109
  • [10] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Simon Vyse
    Paul H. Huang
    [J]. Signal Transduction and Targeted Therapy, 4
12345